bullish

Hanmi Pharm

Hanmi Pharm (128940 KS/Buy)Focus on Beijing Hanmi’s Recovery and Pipeline Progress

100 Views03 Aug 2026 13:58
Broker
Focus on Beijing Hanmi’s recovery and pipeline progressMaintain Buy; lower TP to W640,000 (from W700,000) Our target price for Hanmi Pharm is...
What is covered in the Full Insight:
  • Introduction and Overview
  • Financial Performance 2Q26 Review
  • Operating Value and Price Targets
  • Pipeline and Market Strategy
  • 2026 Earnings Outlook and Market Positioning
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 18-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Hanmi Pharm (128940 KS/Buy)Focus on Beijing Hanmi’s Recovery and Pipeline Progress
    03 Aug 2026
x